Cristina Bárcena - Search Results

Year	Number of Results
2009	1
2010	1
2015	2
2016	1
2018	1
2019	2
2024	0

1

Fibre-type-specific and Mitochondrial Biomarkers of Muscle Damage after Mountain Races.

Carmona G, Roca E, Guerrero M, Cussó R, Bàrcena C, Mateu M, Cadefau JA. Carmona G, et al. Among authors: barcena c. Int J Sports Med. 2019 Apr;40(4):253-262. doi: 10.1055/a-0808-4692. Epub 2019 Mar 5. Int J Sports Med. 2019. PMID: 30836391 Free article.

2

Targeting glucosylceramide synthase upregulation reverts sorafenib resistance in experimental hepatocellular carcinoma.

Stefanovic M, Tutusaus A, Martinez-Nieto GA, Bárcena C, de Gregorio E, Moutinho C, Barbero-Camps E, Villanueva A, Colell A, Marí M, García-Ruiz C, Fernandez-Checa JC, Morales A. Stefanovic M, et al. Among authors: barcena c. Oncotarget. 2016 Feb 16;7(7):8253-67. doi: 10.18632/oncotarget.6982. Oncotarget. 2016. PMID: 26811497 Free PMC article.

3

CD5L is a pleiotropic player in liver fibrosis controlling damage, fibrosis and immune cell content.

Bárcena C, Aran G, Perea L, Sanjurjo L, Téllez É, Oncins A, Masnou H, Serra I, García-Gallo M, Kremer L, Sala M, Armengol C, Sancho-Bru P, Sarrias MR. Bárcena C, et al. EBioMedicine. 2019 May;43:513-524. doi: 10.1016/j.ebiom.2019.04.052. Epub 2019 May 8. EBioMedicine. 2019. PMID: 31076347 Free PMC article.

4

Growth arrest-specific protein 6 is hepatoprotective against murine ischemia/reperfusion injury.

Llacuna L, Bárcena C, Bellido-Martín L, Fernández L, Stefanovic M, Marí M, García-Ruiz C, Fernández-Checa JC, García de Frutos P, Morales A. Llacuna L, et al. Among authors: barcena c. Hepatology. 2010 Oct;52(4):1371-9. doi: 10.1002/hep.23833. Hepatology. 2010. PMID: 20730776 Free PMC article.

5

CD5L is upregulated in hepatocellular carcinoma and promotes liver cancer cell proliferation and antiapoptotic responses by binding to HSPA5 (GRP78).

Aran G, Sanjurjo L, Bárcena C, Simon-Coma M, Téllez É, Vázquez-Vitali M, Garrido M, Guerra L, Díaz E, Ojanguren I, Elortza F, Planas R, Sala M, Armengol C, Sarrias MR. Aran G, et al. Among authors: barcena c. FASEB J. 2018 Jul;32(7):3878-3891. doi: 10.1096/fj.201700941RR. Epub 2018 Feb 20. FASEB J. 2018. PMID: 29465313

6

Angiogenin secretion from hepatoma cells activates hepatic stellate cells to amplify a self-sustained cycle promoting liver cancer.

Bárcena C, Stefanovic M, Tutusaus A, Martinez-Nieto GA, Martinez L, García-Ruiz C, de Mingo A, Caballeria J, Fernandez-Checa JC, Marí M, Morales A. Bárcena C, et al. Sci Rep. 2015 Jan 21;5:7916. doi: 10.1038/srep07916. Sci Rep. 2015. PMID: 25604905 Free PMC article.

7

Gas6/Axl pathway is activated in chronic liver disease and its targeting reduces fibrosis via hepatic stellate cell inactivation.

Bárcena C, Stefanovic M, Tutusaus A, Joannas L, Menéndez A, García-Ruiz C, Sancho-Bru P, Marí M, Caballeria J, Rothlin CV, Fernández-Checa JC, de Frutos PG, Morales A. Bárcena C, et al. J Hepatol. 2015 Sep;63(3):670-8. doi: 10.1016/j.jhep.2015.04.013. Epub 2015 Apr 20. J Hepatol. 2015. PMID: 25908269 Free PMC article.

8

GD3 synthase overexpression sensitizes hepatocarcinoma cells to hypoxia and reduces tumor growth by suppressing the cSrc/NF-kappaB survival pathway.

Lluis JM, Llacuna L, von Montfort C, Bárcena C, Enrich C, Morales A, Fernandez-Checa JC. Lluis JM, et al. Among authors: barcena c. PLoS One. 2009 Nov 26;4(11):e8059. doi: 10.1371/journal.pone.0008059. PLoS One. 2009. PMID: 19956670 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

8 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year